Trial Profile
Protocol for the Study of the Effects of S-MPEC (Iferanserin) in Patients With Hemorrhoids
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 May 2014
Price :
$35
*
At a glance
- Drugs Iferanserin (Primary)
- Indications Haemorrhoids
- Focus Therapeutic Use
- Sponsors Ventrus Biosciences
- 30 May 2014 New trial record